by TractManager | Mar 30, 2020 | Health Technology Assessment
Focus of the Report: Use of Scrambler therapy (ST), also referred to as Calmare Pain Therapy and transcutaneous electrical modulation pain reprocessing (Calmare Therapeutics Inc.), for the management of chronic pain related to cancer or cancer treatment.Technology...
by TractManager | Mar 27, 2020 | Health Technology Assessment
Focus of the Report: The focus of the report is on the use of ovarian or internal iliac vein embolization for the treatment of pelvic congestion syndrome (PCS).Technology Description: Embolization is intended to block the blood supply to the enlarged or swollen veins...
by TractManager | Mar 26, 2020 | Clinical Utility Evaluation
This report evaluates the clinical utility of liquid biopsy tests for colorectal cancer (CRC) screening to reduce CRC morbidity and mortality.If you have a Hayes login, click here to view the full report on the Knowledge Center.
by TractManager | Mar 26, 2020 | Health Technology Assessment
Health Problem: Diabetes mellitus (DM) can damage blood vessels, compromising blood flow and oxygen circulation. Resulting tissue hypoxia may contribute to failure of even minor wounds to heal. Chronic foot ulcers in people with DM (DFU) may occur when foot injuries,...
by TractManager | Mar 26, 2020 | Emerging Technology Report
Zeposia (ozanimod) is an oral sphingosine-1 phosphate (S1P) receptor modulator indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in...
Recent Comments